In a study of colorectal cancer, adenovirus-mediated S100A4 overexpression enhanced the viability and migration of colorectal cancer cells; these effects of S100A4 were reduced by treatment with the specific PI3K/Akt signaling inhibitor LY294002 [35]. Here, S100A4 is linked to colorectal cancer.